Inventories, net - Shelf-life (Details) $ in Thousands |
1 Months Ended | 3 Months Ended | 12 Months Ended | ||
---|---|---|---|---|---|
Nov. 30, 2022
USD ($)
|
Aug. 31, 2022
USD ($)
|
May 31, 2023
USD ($)
|
May 31, 2022
USD ($)
|
Feb. 28, 2022
USD ($)
|
|
Inventory Realizable Value | |||||
Inventory charged-off | $ 2,700 | $ 20,633 | $ 73,490 | ||
Number of batches not saleable | 5 | ||||
Raw materials | 16,264 | ||||
Total number of batches manufactured | 9 | ||||
Other Assets | Samsung BioLogics Co., Ltd. ("Samsung") | |||||
Inventory Realizable Value | |||||
Specialized raw materials | $ 2,700 | ||||
Resins | |||||
Inventory Realizable Value | |||||
Inventory charged-off | $ 16,300 | ||||
Other | |||||
Inventory Realizable Value | |||||
Inventory charged-off | $ 63,300 | ||||
Number of batches not saleable | 4 | ||||
Specialized and other raw materials | |||||
Inventory Realizable Value | |||||
Inventory charged-off | $ 10,200 | ||||
Five Batches Of Drug Product | |||||
Inventory Realizable Value | |||||
Raw materials | $ 29,100 | ||||
Four Batches Of Drug Product | |||||
Inventory Realizable Value | |||||
Raw materials | $ 34,200 | ||||
Bulk Drug Substance | |||||
Inventory Realizable Value | |||||
Inventory charged-off | $ 1,700 |
X | ||||||||||
- Definition The number of batches of inventory deemed not saleable, generating inventory write-down. No definition available.
|
X | ||||||||||
- Definition Amount before valuation and LIFO reserves of raw materials classified noncurrent. No definition available.
|
X | ||||||||||
- Definition Information pertaining to realizable value of inventory. No definition available.
|
X | ||||||||||
- Definition Total number of batches not saleable. No definition available.
|
X | ||||||||||
- Definition Carrying value of capitalized payments made in advance for inventory that is expected to be received within one year or the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|